|
- 积分
- 279
- 威望
- 279
- 包包
- 128
|
Title: CD133: molecule of the moment.. P: Q" H/ y! i: ^: U- E- v5 V
Author: Mizrak, D.; Brittan, M.; Alison, M. R.
( }( s* r5 K! c6 S W: I' C$ k# `+ DSource: J Pathol, 2008, 214(1): 3-9
" ], e2 P/ t2 N- C! e( x7 K: K( c
Title: Focus on molecules: prominin-1 (CD133).
5 _2 A- [# e$ {# j9 {2 \ O4 tAuthor: Jaszai, J.; Fargeas, C. A.; Florek, M. (...)0 L2 G4 u! h5 u& n
Source: Exp Eye Res, 2007, 85(5): 585-586
7 }) T' m7 |3 z8 ?( r9 T* z& A
7 I# a1 }* _& b. |! TTitle: CD133.. j; x t( K8 r! u. c. z; Q9 S
Author: Piechaczek, C.9 M7 ?) V% W" N1 [
Source: J Biol Regul Homeost Agents, 2001, 15(1): 101-1027 U9 v; U: L) U7 U0 A
6 J4 J& q( X- e5 @/ ETitle: CD133 as a marker for cancer stem cells: progresses and concerns.$ y! m( b0 Q/ z/ Y% K1 f0 ~
Author: Wu, Y.; Wu, P. Y.4 A" N$ S1 C( h
Source: Stem Cells Dev, 2009, 18(8): 1127-11348 X8 K( F! O. ?& M; C* H! ]
/ K9 W5 T' R' @4 I& R" aTitle: Risk and benefit of CD133+ progenitors.
j: r- ~4 C. P' L) I( kAuthor: Ascione, R.; Madeddu, P.
; i8 ?( ?% F+ m: Z7 s6 kSource: Circ Res, 2009, 105(2): e2% X# J+ r0 ]8 u2 N- G- X
: {! Q8 }! ]' b' X# y, ?' X, h
Title: Targeting CD133 antigen in cancer.& g% ]/ p ^9 O, d
Author: Ferrandina, G.; Petrillo, M.; Bonanno, G. (...) a$ D. d5 D# k! s( Q& V
Source: Expert Opin Ther Targets, 2009, 13(7): 823-837" Y P* U" ]' c0 {: ^/ `) {
+ F: E V) h6 ~6 }( d' q. `' V
Title: Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas./ {0 M' U+ i% o+ {
Author: Ogden, A. T.; Waziri, A. E.; Lochhead, R. A. (...)
! J+ {. Q- K% | Y$ c% xSource: Neurosurgery, 2008, 62(2): 505-514, 514-515 |
|
发表于 2010-7-9 14:12
发表于 2010-7-9 22:47
rogresses and Concerns不好意思，没看到楼上的已经发了这一篇